Preclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes

  • Post author:
  • Post category:

Diabetes exacts a tremendous toll on patients, their families, and society. Autoimmune Type 1 diabetes, often called juvenile-onset diabetes, is caused by a person’s own immune system mistakenly destroying their…

Continue ReadingPreclinical and clinical testing of a stem cell-based combination product for insulin-dependent diabetes

Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product

  • Post author:
  • Post category:

Human embryonic stem cells (hESC), and other related pluripotent stem cells, have great potential as starting material for the manufacture of curative cell therapies. This is primarily for two reasons.…

Continue ReadingMethods for detection and elimination of residual human embryonic stem cells in a differentiated cell product

Development of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors.

  • Post author:
  • Post category:

There are several challenges to the successful implementation of a cellular therapy for insulin dependent diabetes derived from Human Embryonic Stem Cells (hESCs). Among these are the development of functional…

Continue ReadingDevelopment of the Theracyte Cellular Encapsulation System for Delivery of human ES Cell-derived Pancreatic Islets and Progenitors.